Kardigan, Inc. (KARD)
NASDAQ: KARD · Real-Time Price · USD
21.08
+0.58 (2.83%)
Aug 10, 2026, 4:00 PM EDT - Market closed
Kardigan Market Cap
Kardigan has a market cap or net worth of $1.88 billion as of August 10, 2026.
Market Cap
1.88B
Enterprise Value
1.61B
1-Year Change
n/a
Ranking
Category
Stock Price
$21.08
ChartMarket Cap Chart
Since the IPO on June 18, 2026, Kardigan's market cap has increased from $1.40B to $1.88B, an increase of 34.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 1.88B | 2.83% |
| Aug 7, 2026 | 1.83B | 0.69% |
| Aug 6, 2026 | 1.82B | 0.54% |
| Aug 5, 2026 | 1.81B | -1.17% |
| Aug 4, 2026 | 1.83B | 2.60% |
| Aug 3, 2026 | 1.78B | -4.08% |
| Jul 31, 2026 | 1.86B | 1.71% |
| Jul 30, 2026 | 1.83B | 3.75% |
| Jul 29, 2026 | 1.76B | -6.00% |
| Jul 28, 2026 | 1.88B | -1.13% |
| Jul 27, 2026 | 1.90B | 2.36% |
| Jul 24, 2026 | 1.85B | -4.29% |
| Jul 23, 2026 | 1.94B | -5.21% |
| Jul 22, 2026 | 2.04B | -0.22% |
| Jul 21, 2026 | 2.05B | 7.06% |
| Jul 20, 2026 | 1.91B | 1.28% |
| Jul 17, 2026 | 1.89B | 0.52% |
| Jul 16, 2026 | 1.88B | -4.41% |
| Jul 15, 2026 | 1.96B | -1.21% |
| Jul 14, 2026 | 1.99B | -5.40% |
| Jul 13, 2026 | 2.10B | -4.49% |
| Jul 10, 2026 | 2.20B | 0.76% |
| Jul 9, 2026 | 2.18B | 10.04% |
| Jul 8, 2026 | 1.99B | -6.76% |
| Jul 7, 2026 | 2.13B | 0.21% |
| Jul 6, 2026 | 2.12B | -2.34% |
| Jul 2, 2026 | 2.18B | 1.00% |
| Jul 1, 2026 | 2.15B | 1.09% |
| Jun 30, 2026 | 2.13B | -7.92% |
| Jun 29, 2026 | 2.31B | 9.75% |
| Jun 26, 2026 | 2.11B | 4.52% |
| Jun 25, 2026 | 2.02B | 2.50% |
| Jun 24, 2026 | 1.97B | -0.94% |
| Jun 23, 2026 | 1.99B | -2.33% |
| Jun 22, 2026 | 2.03B | 45.02% |
| Jun 18, 2026 | 1.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Agios Pharmaceuticals | 1.93B |
| Forte Biosciences | 1.88B |
| Bicara Therapeutics | 1.84B |
| Generate Biomedicines | 1.84B |
| Damora Therapeutics | 1.84B |
| Syndax Pharmaceuticals | 1.82B |
| Lakefront Biotherapeutics NV | 1.78B |
| Sarepta Therapeutics | 1.77B |